Related Experiment Videos
[Thrombosis, embolism and aggregation inhibitors in surgery]
Fortschritte Der Medizin
|November 4, 1976
Summary
Acetylsalicylic acid significantly reduced fatal pulmonary embolism in hip fracture patients and post-operative vascular reobstruction. This aggregation inhibitor shows protective effects in thrombosis models and clinical trials.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Surgical Research
Background:
- Pulmonary embolism is a significant risk following hip fracture surgery.
- Vascular reobstruction can occur post-operatively, especially with high peripheral vascular resistance.
- Aggregation inhibitors are being studied for their potential protective effects.
Purpose of the Study:
- To evaluate the protective effect of aggregation inhibitors against pulmonary embolism and vascular reobstruction.
- To assess the efficacy of acetylsalicylic acid in clinical settings.
Main Methods:
- Experimental induction of venous thrombosis in animal models.
- Two double-blind clinical trials comparing acetylsalicylic acid with placebo.
- Analysis of fatal pulmonary embolism frequency and post-operative vascular reobstruction rates.
Main Results:
- Preventive treatment with aggregation inhibitors showed a significant difference in the extent of experimentally induced venous thrombosis.
- Acetylsalicylic acid significantly reduced the frequency of fatal pulmonary embolism in patients with hip fractures.
- A lower rate of immediate post-operative vascular reobstruction was observed in patients undergoing vascular surgery.
Conclusions:
- Acetylsalicylic acid demonstrates a protective effect against fatal pulmonary embolism in high-risk surgical patients.
- Aggregation inhibitors are effective in reducing vascular reobstruction and thrombosis.
- Clinical application of acetylsalicylic acid may improve outcomes in orthopedic and vascular surgery.